dc.creatorCorr??a, Jo??o Carlos
dc.creatorBadar??, Roberto Jos?? da Silva
dc.creatorBumroongkit, Chaiwat
dc.creatorMera, Jorge Ra??l
dc.creatorDolmann, Alberto Lorenzo
dc.creatorMart??nez, Luis Guillermo Ju??rez
dc.creatorMayrinck, Lusane Romero
dc.creatorTamez, Ricardo
dc.creatorYang, Joanna Y.
dc.date.accessioned2019-05-22T15:39:45Z
dc.date.available2019-05-22T15:39:45Z
dc.date.issued2003
dc.identifier0149-2918
dc.identifierhttp://repositorio.ufba.br/ri/handle/ri/17525
dc.identifierv. 25, n. 5
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/2708903
dc.description.abstract
dc.languageen
dc.rightsrestrito
dc.sourcehttp://dx.doi.org.ez10.periodicos.capes.gov.br/10.1016/S0149-2918(03)80132-7
dc.subjectGatifloxacin
dc.subjectCeftriaxone
dc.subjectClarithromycin
dc.subjectErythromycin
dc.subjectCerythromycin
dc.subjectCommunity-acquired pneumonia
dc.subjectTolerability
dc.titleRandomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization
dc.typeArtigo de Peri??dico


Este ítem pertenece a la siguiente institución